Olusegun Adesola BUSARI, Timothy Olusegun OLANREWAJU, Olufemi Olumuyiwa DESALU, Oladimeji George OPADIJO, Ahmed Kayode JIMOH, Segun Matthew AGBOOLA, Olusogo Ebenezer BUSARI, Olaleye OLALEKAN

Impact of patients’ knowledge, attitude and practices on hypertension on compliance with antihypertensive drugs in a resource-poor setting

AMAÇ: Çalışmanın amacı hipertansiyonu olan 240 yetişkin Nijerya Afrikalı’nın hipertansiyon üzerine bilgi, tutum ve uygulamalarının antihipertansif ilaç uyumuna etkilerini değerlendirmektir. YÖNTEM: Bu tanımlayıcı araştırma, Nisan 2008 ve Mart 2009 tarihleri arasında Nijerya’nın İdo Ekiti eyaletinde bulunan Federal Tıp Merkezi Kardiyoloji Kliniğine başvuran 240 hipertansiyonlu yetişkin üzerinde gerçekleştirilmiştir. Hastane güney Nijerya’nın batısındaki kırsal kesimde kurulu bir sağlık kuruluşudur. BULGULAR: Katılımcılardan, 114 hasta (%47,5) erkek, 126 hasta (%52,5) kadındı. Yaş ortalaması 48,8±13,2 yıl olarak bulunmuştur. Ortalama sistolik ve diyastolik kan basıncı 156,8±25,1 mmHg ve 98,4±18,7 mmHg ölçülmüştür. Katılımcıların yarıdan biraza azı (%47,1) hastalığı konusunda geniş bilgiye sahiptir. Ancak, 141 (%58,8) kişi kullandığı antihipertansif ilaç konusunda detaylı bilgiye sahiptir. Hipertansiyon konusunda bilgi düzeyi kadınlarda erkeklere göre daha iyi bulunmuştur (sırasıyla %59,3 ve %40,7, p=0.014). Tedavide ilaca uyum sadece 77 hastada (%32,1) yeterli bulundu. Uyumsuzluğun nedenleri: hastalık hakkında bilgisizlik ve hastalığın uzun vadeli tedavi gerektirdiğini bilmeme (95, %32,6); ilaçların pahalı olması (63, %21,7); dini uygulamalar ve kültürel inançlar (37, %12,5) advers ilaç reaksiyonları (19, %6,5); tedaviye yetersiz ulaşım (18, %6,2) alternatif tıp kullanımı (60, %20,5). SONUÇ: Araştırmaya katılan hipertansif hastaların çoğunluğunda, ilaca uyum ve hastalık konusunda bilgi düzeyi zayıfolduğu görülmüştür. Kuşkusuz; topluma ve özellikle de hastalara yönelik daha etkin eğitim stratejileri geliştirilmesine ihtiyaç bulunmaktadır.

Az gelirli toplumlarda hipertansiyon hastalarının bilgi, tutum ve uygulamalarının antihipertansif ilaçlara uyuma etkisi

AIM: The study objective was to assess the knowledge, attitudes and practices on hypertension of 240 adult Nigerian Africans with hypertension and their impact on compliance with antihypertensive drugs METHOD: It was a descriptive survey of 240 consented consecutive adult patients with hypertension who attended the Cardiology Clinic of the Federal Medical Centre, Ido-Ekiti, Nigeria, between April 2008 and March 2009. The hospital is rural health institution in south west Nigeria RESULTS: One hundred and fourteen patients (47.5%) were men and 126 (52.5%) were women. Mean age was 48.8±13.2 years. Mean systolic and diastolic BP were 156.8±25.1 mmHg and 98.4±18.7 mmHg respectively. Only less than half (47.1%) showed good knowledge of their hypertension. However, 141 (58.8%) possessed good knowledge of their antihypertensive drugs. Knowledge of hypertension was better in women than in men (59.3% vs 40.7%, p=0.014). Compliance to medications was good in only 77 (32.1%) of the patients. The reasons attributed to included: poor knowledge of the disease and ignorance of the need for long-term treatment (95, 32.6%); high cost of medications (63, 21.7%); religious practices and cultural beliefs (37, 12.5%); adverse drug reactions (19, 6.5%); inadequate access to medical care (18, 6.2%); and use of complimentary medications (60, 20.5%). CONCLUSION: The majority of our hypertensive patients still have a poor knowledge of their disease with a significant negative impact on compliance with medications. No doubt, there is a need to invent more effective education strategies directed towards the public in general and the patients in particular.

PDF

___

1. Chobanian AU, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr et al. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. JAMA. 2003; 289: 2560-2572.

2. Whelton PK. Epidemiology of hypertension. Lancet. 1994; 344: 101-106.

3. Akinkugbe OO. World epidemiology of hypertension in blacks. J Clin Hypertens. 1987; 3: 1S-8S.

4. Dodu RSA. Emergence of cardiovascular diseases in developing countries. Cardiology. 1988; 75: 56-64.

5. Nissinen A, Bothig S, Granroth H, Lopez AD. Hypertension in Developing Countries. World Health Stat Q 1988; 41: 141-154.

6. World Health Organization. Cardiovascular Diseases in Developing Countries. World Health Stat Q. 1993; 46: 90-150.

7. Akinkugbe OO. Current Epidemiology of Hypertension in Nigeria. Archives of Ibadan Medicine. 2002; 1: 3-5.

8. Non-communicable Diseases in Nigeria. Final Report of the National Survey. Federal Ministry of Health National Expert Committee on Non- Communicable Diseases, 1997.

9. Kadiri S, Walker O, Salako BL, Akinkugbe OO. Blood Pressure, Hypertension and Correlates in Urbanized Workers in Ibadan, Nigeria–a revisit. J Hum Hypertens. 1999; 13: 23-27.

10. Sackett DL, Haynes RB, Gibson ES, Taylor DW, Roberts RS, et al. Randomized Clinical Trial of Strategies For İmproving Medication Compliance in Primary Hypertension. Lancet. 1975; 1: 1205- 1207.

11. Janz NK, Becker MH. The Health Belief Model: a Decade Later. Health Educ Q. 1984; 11: 1-47.

12. Rosenstock IM, Strecher VJ, Becker MH. Social Learning Theory and the Health Belief Model. Health Educ Q. 1988; 15: 175-183.

13. Farquhar JW, Maccoby N, Wood PD. Education and communication studies. In: Holland WW, Detels R, Knox G, eds. Oxford Textbook of Public Health. Oxford, UK. Oxford University Press, 1985, p. 207-221.

14. Proschaska J, DiClemente CC, Norcross JC. In Search of How People Change: APPLİcation to Addictive Behaviours. Am Psychol. 1992; 47: 1102-1114.

15. Adetuyibi A. Diabetes in the Nigerian African III. Socioeconomic Aspects. Trop Geogr Med. 1976; 28: 155-168.

16. Famuyiwa OO, Edozien EM, Ukoli CO. Social, Cultural and Economic Factors in the Management of Diabetes Mellitus in Nigeria. Afr J Med Sci. 1985; 14: 145-154.

17. Fabiyi AK, Kolawole BA, Adefehinti O, Ikem RT. The Impact of Knowledge, Attitude, Practice and Beliefs of Type 2 Nigerian Diabetic Patients on Drug Compliance. Diab Int. 2002; 12(1): 15-17.

18. Freeman V, Fraser H, Forrester T, Wilks R, Cruickshank J, Rotimi C et al. A Comparative Study of Hypertension Prevalence, Awareness, Treatment and Control Rates in St Lucia, Jamaica and Barbados. J Hypertens. 1996; 14: 495-501.

19. Aubert L, Bovet P, Gervason JP, Rivebogora A, Waeber B, Paccacid F et al. Knowledge, Attitudes, and Practices on Hypertension in a Country in Epidemiological Transition. Hypertension. 1998; 31: 1136-1145.

20. Prochaska JO, Di Clemente C. Towards a Comprehensive Model of Change. In: Miller W, Heather N, eds. Treating Addictive Behaviours: Processes of Change. New York, NY. Plenum Press, 1986, p. 3-27.

21. Yakovlevitch M, Black HR. Resistant Hypertension in a Tertiary Care Clinic. Arch Intern Med. 1991: 151: 1786-1792.

22. Stephenson BJ, Rowe BH, Haynes RB, Macharia WM, Leon G. Is this Patient Taking the Treatment as Prescribed? JAMA. 1993; 269: 2779-2781.

23. O’Rorke JE, Richardson WS. What to do When Blood Pressure is Difficult to Control. BMJ. 2001; 322(7296): 1229-1232.

24. Bovet P, Burnier M, Madeleine G, Waeber B, Paccaud F. Monitoring One-Year Compliance to Antihypertension Medication in the Seychelles. Bulletin of the World Health Organization. 2002; 80 (1): 33-39.

25. Moname M, Bohn RL, Gurwitz JH, et al. The Effects of Initial Drug Choice and Comorbidity on Antihypertensive Therapy. International Journal of Clinical Practice. 1999; 53: 37-38.

26. Lee JY, Kusek JW, Greene PG, Bernhad S, Norris K, Smith D et al. Assessing Medication Adherence By Pill Count and Electronic Monitoring in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study. American Journal of Hypertension. 1996; 9: 719-725.

27. Mengden T, Un S, Dusing R, Weisse B, Vetter H. Drug Compliance Decreases Between Clinic Visits: the Effect of White Coat Compliance on 24-hour Ambulatory Blood Pressure Monitoring. J Hypertens. 2000; 18 (Suppl 4): S169.

28. Schwartz GL, Sheps SG. A review of the Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Current Opinion in Cardiology. 1999; 14: 161-165.

29. Luscher TF, Vetter H, Siegenthaler W, Vetter W. Compliance in Hypertension: Facts and Concepts. J Hypertens 1985; 3: 53-59.

30. Bertholet N, Favrat B, Fallab-Stubi CL, Brunner HR, Burnier M. Why Objective Monitoring of Compliance is İmportant in the Management of Hypertension. J Clin Hypertens. 2002; 2: 258- 262.

31. Rudd P. Clinicians and Patients With Hypertension: Unsettled İssues about Compliance. American Heart Journal. 1995; 130: 572-587.

32. Hungerbuhler P, Bovet P, Shamlaye C, Burnand B, Waeber B. Compliance With Medication Among Outpatients With Uncontrolled Hypertension in the Seychelles. Bulletin of the World Health Organization. 1995; 73: 437-442.

33. Gruninger UJ, Duffy FD, Goldstein MG. Patient Education in the Medical Encounter: How to Facilitate Learning, Behaviour Change and Coping. In: Lipkins M, Lazare A, Putnam S (eds). The Medical Interview. New York. Springer, 1994.

34. Beaglehole R. Global cardiovascular disease prevention: time to get serious. Lancet. 2001; 161: 1501-1508.